Kennedy, Nicholas ALamb, Christopher ABerry, Susan HWalker, Alan WMansfield, JohnParkes, MilesSimpkins, RachelTremelling, MarkNutland, SarahUK IBD Genetics ConsortiumParkhill, JulianProbert, ChrisHold, Georgina LLees, Charlie W.2018-02-202018-02-202018-03Kennedy, N A, Lamb, C A, Berry, S H, Walker, A W, Mansfield, J, Parkes, M, Simpkins, R, Tremelling, M, Nutland, S, UK IBD Genetics Consortium, Parkhill, J, Probert, C, Hold, G L & Lees, C W 2018, 'The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease', Inflammatory Bowel Diseases, vol. 24, no. 3, pp. 583-592. https://doi.org/10.1093/ibd/izx0611078-0998ORCID: /0000-0001-5099-8495/work/42316360http://hdl.handle.net/2164/10060Funding was supported by CORE, the Digestive Diseases Foundation and the Wellcome Trust [grant number 097943 to NAK, 093885 to CAL and 098051 to Alan W Walker and Julian Parkhill . Dr. Walker receives core funding support from the Scottish Government Rural and Environmental Science and Analysis Service (RESAS). We also acknowledge the NIHR Biomedical Research Centre awards to Addenbrooke’s Hospital/University of Cambridge School of Clinical Medicine and acknowledge the NIHR Newcastle Biomedical Research Centre.107040296engCrohn’s diseaseNOD2microbiotagenotypeR MedicineWellcome TrustRJournal article10.1093/ibd/izx061243